Ygiene(TM) Hospital Grade antimicrobial sets the new global standard to
eradicate (100% kill) in seconds the most difficult and lethal microorganisms commonly found in health care facilities, including MRSA and
NEWARK, N.J., Aug. 19 /PRNewswire/ -- BioNeutral announces successful testing of its Ygiene(TM) Hospital Grade antimicrobial against antibiotic-resistant microorganisms and spore forms of microorganisms which represent the major source of hospital acquired infections. In the US, Methicillan Resistant Staphylococcus Aureus (MRSA), Vancomycin-resistant Enterococci, Pan-resistant Klebsiellia pneumoniae and Clostridium difficile are but a few of the various lethal microorganisms present in hospital environments which contribute to over two-and-a-half million hospital acquired infections and one-hundred-thousand deaths annually. Using Ygiene(TM) Hospital Grade antimicrobial to routinely disinfect all areas in health care facilities can save many lives and billions of dollars annually in this global problem. Ygiene(TM) Hospital Grade antimicrobial has been found to completely eradicate these harmful microorganisms in seconds, and is still safe for the environment.
Dr. Philip Tierno, Principal Investigator and Head of Microbiology and Immunology at the Langone NYU Medical Center, has stated regarding Ygiene(TM) Hospital Grade antimicrobial: "No chemical formulation I have ever tested gives a quicker and more complete kill, has a broader spectrum of activity and is more 'green.'"
Dr. Andy Kielbania, Chief Scientist at BioNeutral, stated, "Despite the
use of Lysol(R), Clorox(R) bleach, Oxivir(TM)Tb, Medica DC Germicidal
Solution, Asepticare(R) TB+II, Germ Control 24 by Pure Biosciences and many
other commercial disinfectants, the epidemic of infections continues in
health care facilities. Most of these products are not sporicidal and
either have no effect on the more difficult organisms,
|SOURCE BioNeutral Laboratories Corporation|
Copyright©2008 PR Newswire.
All rights reserved